Its the Business Concept and Science-Not the Numbers Think about it. Why do investors keep coming back to biotech? Why do VC’s, hedge funds and traders like biotech? One reason is that it is not just dependent on fundamentals and financial metrics. Biotech thrives on medical news, scientific breakthroughs, potential cures for serious diseases and [...]
…”tools to redesign the living world”… No time to write about this now but it is a biotech theme with great interest. Will provide content at a later date. Is Randal J. Kirk Biotech’s Best Investor? – Matthew Herper – The Medicine Show – Forbes Synthetic biology and evolution : The New Yorker Synthetic Biology [...]
Will the GOP cut the NIH budget? Turf battles at the Institutes to follow. Who knew there were only two breakthroughs in mental health drugs: Thorazine and Lithium? Federal Research Center Will Help Develop Medicines – NYTimes.com Most experts believe the PET Imaging procedure can be helpful. Alzheimer’s Scan Might Help Spot Disease Alzheimer’s Association [...]
Venture Capitalists invested $21.8B in 2010 an increase of 19% over the prior year. Biotechnology was up 3% over the prior year to $3.7B with 460 deals. Software was the leader rising 20% to $4B. Medical Device was flat year over year with $2.3B invested. ANNUAL VENTURE INVESTMENT INCREASES FOR FIRST TIME SINCE 2007, ACCORDING [...]
Significant Life Science News This Week Diagnostic Tests Can Be Patented, U.S. Court Rules – Bloomberg New Blood-Screening Advised – WSJ.com WABE: FDA Rules On Avastin Breast Cancer Drug (2010-12-17) Long legal fight ahead for health law – Politics – More politics – msnbc.com Health-Care Reform 2010 – Tracking the National Health-Care Debate
“A Deadly Misdiagnosis” by Michael Specter An interesting article in the November 15 New Yorker on the Tuberculosis epidemic in India stresses the need for more accurate diagnostic tests and how the Cepheid TB assay can save lives. The author reports on the complexity and economics of India’s healthcare delivery and the difficulty in adopting [...]
